Kazuyuki Inoue

Comparison of Ipragliflozin and Pioglitazone Effects on Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Randomized, 24-Week, Open-Label, Active-Controlled Trial

Daisuke Ito, Satoshi Shimizu, Kazuyuki Inoue et al. · Diabetes Care · 2017 · 279 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients

Keizo Yoshida, Kenichi Ito, Kazuhiro Sato et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2002 · 229 citations

Medicine, Pharmacology, Psychiatry +16

Prediction of Antidepressant Response to Milnacipran by Norepinephrine Transporter Gene Polymorphisms

Keizo Yoshida, Hitoshi Takahashi, Hisashi Higuchi et al. · American Journal of Psychiatry · 2004 · 158 citations

Medicine, Pharmacology, Psychiatry +17

Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients

Masatomo Miura, Shigeru Satoh, Kazuyuki Inoue et al. · European Journal of Clinical Pharmacology · 2007 · 149 citations

Pharmacy, Genetics, Pharmacokinetics +16

Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder

Keizo Yoshida, Shingo Naito, Hitoshi Takahashi et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2002 · 91 citations

Medicine, Pharmacology, Psychiatry +17